{"id":"2b73db3c-839f-4443-86b4-e1bb8609d3be","name":"CorTec","slug":"cortec","description":"CorTec is a Freiburg-based clinical-stage neurotechnology company developing the [Brain Interchange](/models/cortec-brain-interchange) BCI system, a fully implantable bidirectional brain-computer interface for stroke motor rehabilitation. First and only European company with an FDA-approved BCI clinical trial. FDA Breakthrough Device Designation and TAP Program acceptance (April 2026). Three patients implanted at Harborview Medical Center, Seattle. 500+ days of continuous stable operation demonstrated.","status":"private","founded":2010,"hq":"Freiburg, Germany","hqLat":47.9960901,"hqLng":7.8494005,"hqGeocodedAt":"2026-08-23T21:15:39.839Z","hqAddress":null,"hqPrecision":null,"website":"https://www.cortec-neuro.com","fundingTotal":null,"type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":50,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://brain-interchange.com/","title":"CorTec Brain Interchange — Fully implantable BCI system","sourceName":"CorTec (official)"},{"url":"https://www.mobihealthnews.com/news/cortec-becomes-first-german-bci-company-get-fda-breakthrough-designation","title":"CorTec becomes first German BCI company to get FDA Breakthrough designation","sourceName":"MobiHealthNews"},{"url":"https://cortec-neuro.com/brain-interchange-system/implantable-system/","title":"Brain Interchange","sourceName":"CorTec"},{"url":"https://cortec-neuro.com/successful-second-human-implantation-bci-system/","date":"2026-02-10","title":"CorTec Announces Successful Second Human Implantation of Its Brain-Computer Interface System","sourceName":"CorTec"}],"keyFacts":[{"label":"Brain Interchange (company-claimed)","value":"Fully implantable closed-loop BCI that records neural activity and delivers stimulation."},{"label":"Stroke trial (company-claimed)","value":"Second human implant in an FDA-approved stroke trial at Harborview; still investigational."}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:26:47.782Z","updatedAt":"2026-10-12T22:10:36.116Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/cortec","url":"https://registry.deploy.report/companies/cortec","name":"CorTec","description":"CorTec is a Freiburg-based clinical-stage neurotechnology company developing the [Brain Interchange](/models/cortec-brain-interchange) BCI system, a fully implantable bidirectional brain-computer interface for stroke motor rehabilitation. First and only European company with an FDA-approved BCI clinical trial. FDA Breakthrough Device Designation and TAP Program acceptance (April 2026). Three patients implanted at Harborview Medical Center, Seattle. 500+ days of continuous stable operation demonstrated.","identifier":"2b73db3c-839f-4443-86b4-e1bb8609d3be","foundingDate":"2010","address":"Freiburg, Germany","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":4,"primary_source_types":["primary-company-ir"]}}}